DNDN, LPHI, OSCI, PRGN, GVCM, TRNP Have Also Been Removed From Naked Short List Today.

0 Comments | M2 Presswire, March, 2008

M2 PRESSWIRE-11 March 2008-BUYINS.NET: DNDN, LPHI, OSCI, PRGN, GVCM, TRNP Have Also Been Removed From Naked Short List Today(C)1994-2008 M2 COMMUNICATIONS LTD

RDATE:11032008

BUYINS.NET, www.buyins.net.

Dendreon Corp. (NASDAQ: DNDN) a biotechnology company, engages in the discovery, development, and commercialization of therapeutics that harness the immune system to fight cancer. Its product portfolio includes active cellular immunotherapy, monoclonal antibody, and small molecule product candidates to treat various cancers. The company's product candidates include Provenge (sipuleucel-T), an active cellular immunotherapy that is in FDA priority review status for the treatment of asymptomatic, metastatic, androgen-independent prostate cancer;...

Read the rest of this article with a Free Trial at HighBeam Research.
Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:
  1. You are currently: a Guest |
  4.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)